Annovis Bio, Inc.ANVSNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank88
3Y CAGR+15.1%
5Y CAGR+52.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+15.1%/yr
vs +248.8%/yr prior
5Y CAGR
+52.5%/yr
Recent deceleration
Acceleration
-233.6pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
8.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $25.22M | +26.1% |
| 2024 | $20.00M | -48.5% |
| 2023 | $38.79M | +134.9% |
| 2022 | $16.52M | +94.8% |
| 2021 | $8.48M | +177.6% |
| 2020 | $3.05M | +293.4% |
| 2019 | $776256.00 | +595.5% |
| 2018 | $111608.00 | -59.2% |
| 2017 | $273370.00 | - |